Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital

This is a pilot study comparing the 30 and 60 day relapse rates for schizophrenic patients treated with long-acting injectable antipsychotics versus traditional oral antipsychotics in a community hospital setting. This is a retrospective cohort study and medical records were reviewed to gather data...

Descripción completa

Detalles Bibliográficos
Autores principales: Espiridion, Eduardo D, Lewandrowski, Callum, Shahriari, Shiva, Bestoyong, Dorothy F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389030/
https://www.ncbi.nlm.nih.gov/pubmed/30820394
http://dx.doi.org/10.7759/cureus.3775
_version_ 1783397871471558656
author Espiridion, Eduardo D
Lewandrowski, Callum
Shahriari, Shiva
Bestoyong, Dorothy F
author_facet Espiridion, Eduardo D
Lewandrowski, Callum
Shahriari, Shiva
Bestoyong, Dorothy F
author_sort Espiridion, Eduardo D
collection PubMed
description This is a pilot study comparing the 30 and 60 day relapse rates for schizophrenic patients treated with long-acting injectable antipsychotics versus traditional oral antipsychotics in a community hospital setting. This is a retrospective cohort study and medical records were reviewed to gather data involving readmission rates. We analyzed the data using relative risk (RR) for the 30 days and 60 days after patient discharge from the behavioral health unit of a community hospital.
format Online
Article
Text
id pubmed-6389030
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-63890302019-02-28 Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital Espiridion, Eduardo D Lewandrowski, Callum Shahriari, Shiva Bestoyong, Dorothy F Cureus Psychiatry This is a pilot study comparing the 30 and 60 day relapse rates for schizophrenic patients treated with long-acting injectable antipsychotics versus traditional oral antipsychotics in a community hospital setting. This is a retrospective cohort study and medical records were reviewed to gather data involving readmission rates. We analyzed the data using relative risk (RR) for the 30 days and 60 days after patient discharge from the behavioral health unit of a community hospital. Cureus 2018-12-24 /pmc/articles/PMC6389030/ /pubmed/30820394 http://dx.doi.org/10.7759/cureus.3775 Text en Copyright © 2018, Espiridion et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Espiridion, Eduardo D
Lewandrowski, Callum
Shahriari, Shiva
Bestoyong, Dorothy F
Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title_full Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title_fullStr Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title_full_unstemmed Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title_short Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
title_sort readmission rates of patients with schizophrenia treated with depot antipsychotics versus oral antipsychotics in a community hospital
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389030/
https://www.ncbi.nlm.nih.gov/pubmed/30820394
http://dx.doi.org/10.7759/cureus.3775
work_keys_str_mv AT espiridioneduardod readmissionratesofpatientswithschizophreniatreatedwithdepotantipsychoticsversusoralantipsychoticsinacommunityhospital
AT lewandrowskicallum readmissionratesofpatientswithschizophreniatreatedwithdepotantipsychoticsversusoralantipsychoticsinacommunityhospital
AT shahriarishiva readmissionratesofpatientswithschizophreniatreatedwithdepotantipsychoticsversusoralantipsychoticsinacommunityhospital
AT bestoyongdorothyf readmissionratesofpatientswithschizophreniatreatedwithdepotantipsychoticsversusoralantipsychoticsinacommunityhospital

Ejemplares similares